SCHEMBL8337402

SCHEMBL8337402

CC(C)(C)OC(=O)NC(C(=O)Nc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.59
CTSK P43235 1/20 0.59
S1PR3 Q99500 2/20 0.57
ALDH1A1 P00352 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KLK7 P49862 2/20 0.47
SCN9A Q15858 1/20 0.46
HDAC8 Q9BY41 1/20 0.45
BACE1 P56817 2/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 1/20 0.45
ATM Q13315 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
MAPT P10636 1/20 0.45
NPY5R Q15761 1/20 0.44
EP300 Q09472 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8334410 1.00 CTSS (0.59) CTSSCTSKS1PR3ALDH1A1SMN1; SMN2
SCHEMBL31048635 0.91 CTSK (0.66) CTSSCTSKS1PR3KLK7SCN9A
SCHEMBL8338149 0.91 CTSK (0.66) CTSSCTSKS1PR3KLK7SCN9A
SCHEMBL8334434 0.90 CTSS (0.59) CTSSCTSKS1PR3ALDH1A1SMN1; SMN2
SCHEMBL8336332 0.89 CTSS (0.60) CTSSCTSKS1PR3ALDH1A1SMN1; SMN2
SCHEMBL31560139 0.88 CTSS (0.59) CTSSCTSKS1PR3ALDH1A1SMN1; SMN2
SCHEMBL8338474 0.88 CTSS (0.59) CTSSCTSKALDH1A1SMN1; SMN2KLK7
SCHEMBL29866403 0.88 CTSS (0.59) CTSSCTSKS1PR3ALDH1A1SMN1; SMN2
SCHEMBL4597362 0.88 CTSS (0.59) CTSSCTSKS1PR3KLK7SCN9A
SCHEMBL4597368 0.88 CTSS (0.59) CTSSCTSKS1PR3KLK7SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022534-A1 ARYLGLYCINE DERIVATIVES FOR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed
WO-2004022528-A2 ARYLGLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed